|
|
 |
|
 |
|
|
|
|
|
Home > Lawyers
>
Deirdre M. Dorval
Deirdre M. Dorval
Education | Publications
|
Biography
Deirdre’s principal area of practice is intellectual property, primarily in the areas of Hatch-Waxman Paragraph IV pharmaceuticals, chemical arts, biotechnology, and other life science-related areas. Her litigation experience includes trial experience, formulating claim construction and litigation strategy, drafting various dispositive and non-dispositive motions, drafting preliminary injunction motions, identifying prior art to invalidate asserted patents, handling various discovery matters, preparing witnesses for deposition and trial testimony, and preparing expert reports. Deirdre also has experience formulating inter partes reexamination requests and analyzing intellectual property portfolios.
|
Education and Professional Background
- Harvard Law School, J.D., 2009
- College of the Holy Cross, B.A. Biology and French, magna cum laude, 2006 (Phi Beta Kappa, Alpha Sigma Nu, Pi Delta Phi)
- Admitted to practice: Texas, 2009; District of Columbia, 2013
Publications and Presentations
View All
- "Federal Circuit Reopens Bid to Take Generic Zegerid Off the Market," V&E IP Insights E-communication, September 7, 2012 (co-author)
- “Protein splicing of the three Pyrococcus abyssi ribonucleotide reductase inteins,” Biochem. Biophys. Res. Commun, 2009 (co-authored with K.V. Mills, A.M. Kerrigan, T.L. Powers, and J.N. Reitter)
- “Catalysis of individual steps of protein splicing of the Pyrococcus abyssi PolII intein” and “Protein splicing of a non-canonical Clostridium thermocellum intein with N-terminal Gln,” ASBMB, 2006
<< Back to Top
|
|
 |
|
|
|
|
|
|
|
Full Biography
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2200 Pennsylvania Avenue NW Suite 500 West Washington, DC 20037-1701
Tel +1.202.639.6590
Fax +1.202.879.8970
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |